[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:non-cystic-fibrosis-bronchiectasis":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":35,"states":36},"Non-cystic Fibrosis Bronchiectasis",4,[7,15,22,28],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06603246","A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease",[11],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:18:43.501109Z","2026-05-05T02:43:29.473813Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT06242795","Hypertonic Saline in NCFB",[19],"Phase 4","2026-08-26T02:18:46.948970Z","2026-05-05T02:43:28.510753Z",{"nct_id":23,"title":24,"phases":25,"status":12,"updated_at":26,"content_modified":27},"NCT05860803","Breathing Training and Exercise Capacity in Non-CFB",[],"2026-08-26T02:18:35.425468Z","2026-05-05T02:43:27.321237Z",{"nct_id":29,"title":30,"phases":31,"status":12,"updated_at":33,"content_modified":34},"NCT07709494","A Phase 1a\u002F1b Study to Investigate the Safety, Tolerability, Microbiological Response, and Pharmacokinetics of Inhaled Rev-56 in Adult Healthy Volunteers and Adult Non-cystic Fibrosis Bronchiectasis (NCFB) Patients With Chronic P. Aeruginosa",[32],"Phase 1","2026-08-26T02:15:24.145250Z","2026-07-19T19:36:05.091378Z",[],[]]